Opens in a new tab

German Medical Cannabis Distribution Platforms

German Medical Cannabis Distribution Platforms
Country
GermanyGermany
Listing ID
L#20261068
Target Price
Price on request
Revenue
TBD
EBITDA
TBA

Description

Multiple licensed German pharmaceutical distribution companies holding GDP and narcotics authorizations for the distribution of medical cannabis. These turnkey platforms enable immediate market entry into Germany with fully compliant infrastructure already in place.

A fully licensed pharmaceutical distribution entity in Germany, purpose-built for the medical cannabis sector. The business operates under a streamlined, asset-light model, leveraging established third-party partners for logistics, compliance, and quality assurance, ensuring efficient operations and a scalable foundation for rapid market entry.

Listing Details

  • Fully licensed German medical cannabis wholesaler authorized to register, distribute, and commercialize medical cannabis products.
  • Clean corporate structure with no debt, pre-revenue status, and all required licenses already in place.
  • Existing agreements with licensed warehousing and logistics providers for secure storage and distribution.
  • Appointed Responsible Person for narcotics and medical cannabis release, who is willing to remain with the business.
  • The licensing process typically takes 12–18 months, offering a significant immediate time-to-market advantage for an acquirer.
  • Well-suited for international producers, distributors, or investors seeking a compliant, turnkey platform to enter Germany or the broader EU market.

Basic Details

Listing ID
L#20261068
Country
Germany
Industry
Consumer Product
Deal Status
Available
Target Price
Price on request
Revenue
TBD
EBITDA
TBA
Revenue Multiple
TBD
EBITDA Multiple
TBD

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities

United StatesUnited StatesConsumer ProductL#20261077

US Subscription-Led Beauty & Medical Aesthetics Marketplace

This confidential investment opportunity represents a fast-growing, subscription-led marketplace operating within the U.S. beauty and medical aesthetics sector. The business addresses a highly fragmented market characterized by underutilized appointment capacity, inconsistent customer retention, and limited demand-generation capabilities for independent operators.…

Target Price
$10,000,000
Revenue
$2,600,000
EBITDA
TBA